Montgomery County Public Health District announced the arrival of the federal Test-to-Treat program intended to treat patients testing positive for COVID-19 on April 5. President Joe Biden’s administration launched the program March 8 to allow for the distribution of oral antiviral pills, such as Paxlovid—developed by Pfizer—and Molnupiravir—developed by Merck. Paxlovid received a U.S. Food and Drug Administration emergency use authorization, or EUA, on Dec. 22, while Molnupiravir received its EUA on Dec. 23.
Original Article: https://communityimpact.com/houston/conroe-montgomery/coronavirus/2022/04/05/federal-covid-19-treatment-service-announced-in-montgomery-county/
Follow us for instant updates:
Leave a Reply